Owned by the Association for International Promotion & Study in Tumors (APSIT)
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
Patient Derived Organoids (PDOs) emerged as the best technology to develop ex vivo tumor avatars. Whether drug testing on PDOs to identify efficient therapies will bring clinical utility by improving patient s...